Literature DB >> 19482659

Treatment of endometriosis-related pain: options and outcomes.

Edgardo Somigliana1, Paola Vigano, Giussy Barbara, Paolo Vercellini.   

Abstract

Endometriosis-associated pain represents a challenge for both the patient and the health care provider since it is often difficult to design treatment strategies resulting in improvement of the symptoms. The association between endometriosis stage and severity of pelvic symptoms is limited. Surgery is generally considered the first line treatment in women affected, at least in those who have not been previously operated, but there are several situations in which medical treatments are useful. Given their good tolerability, minor metabolic effects and low cost, progestogens with or without the addition of estrogens, can be considered the drugs of choice and are currently the only safe and inexpensive alternative to surgery. Progestogens are effective in controlling pain symptoms in approximately three of four women with endometriosis. There is little or no difference in the effectiveness of GnRH agonist and add-back treatment in comparison with other medical treatments for endometriosis while the surgical interruption of pelvic nerve pathways entail some clinically relevant risks.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19482659     DOI: 10.2741/e41

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  3 in total

1.  Laparoscopic surgery for endometriosis.

Authors:  Celine Bafort; Yusuf Beebeejaun; Carla Tomassetti; Jan Bosteels; James Mn Duffy
Journal:  Cochrane Database Syst Rev       Date:  2020-10-23

2.  Endometriosis-induced vaginal hyperalgesia in the rat: role of the ectopic growths and their innervation.

Authors:  Stacy L McAllister; Kristina A McGinty; David Resuehr; Karen J Berkley
Journal:  Pain       Date:  2009-10-12       Impact factor: 6.961

3.  Effectiveness of neuromuscular electrical stimulation for endometriosis-related pain: A protocol of systematic review and meta-analysis.

Authors:  Zi-Yang Zhang; Jing Wang; Yi-Lin Fan; Bi-Yao Wang; Wei-Ting Zhang
Journal:  Medicine (Baltimore)       Date:  2020-06-19       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.